Fresenius Medical Care AG (ETR:FME – Get Free Report) crossed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of €39.15 and traded as high as €42.28. Fresenius Medical Care shares last traded at €41.93, with a volume of 522,258 shares trading hands.
Fresenius Medical Care Price Performance
The business has a 50-day simple moving average of €39.03 and a two-hundred day simple moving average of €39.17. The company has a quick ratio of 0.80, a current ratio of 1.20 and a debt-to-equity ratio of 83.29. The stock has a market capitalization of $12.54 billion, a price-to-earnings ratio of 19.03, a P/E/G ratio of 0.42 and a beta of 0.82.
About Fresenius Medical Care
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.
Featured Stories
- Five stocks we like better than Fresenius Medical Care
- Why Johnson & Johnson’s Earnings Dip Looks Like a Buying Opportunity
- CPI Comes In Cool: Why It Could Revive These 3 Rate-Sensitive Stocks
- Why ASML’s AI Monopoly Is Still Getting Stronger
- Apple’s AI Toll Booth Thesis Faces Its Biggest Test Yet Before Earnings
Receive News & Ratings for Fresenius Medical Care Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care and related companies with MarketBeat.com's FREE daily email newsletter.
